Explore

Trendline Trendline
Lysoway Therapeutics Initiates Phase I Clinical Trial for Neurodegenerative Disease Treatment

Lysoway Therapeutics Initiates Phase I Clinical Trial for Neurodegenerative Disease Treatment

Lysoway Therapeutics Initiates Phase I Clinical Trial for Neurodegenerative Disease Treatment
Trendline Trendline
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for AI-Driven Development

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for AI-Driven Development

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for AI-Driven Development
Trendline Trendline
Agenus Advances BOT+BAL Immunotherapy with Phase 3 Trial and Strategic Collaboration

Agenus Advances BOT+BAL Immunotherapy with Phase 3 Trial and Strategic Collaboration

Agenus Advances BOT+BAL Immunotherapy with Phase 3 Trial and Strategic Collaboration
Trendline Trendline
NFL Announces 2026 Schedule Release, Including International Games

NFL Announces 2026 Schedule Release, Including International Games

NFL Announces 2026 Schedule Release, Including International Games
Trendline Trendline
Anixa Biosciences Announces Positive Survival Data from Phase 1 Ovarian Cancer CAR-T Therapy Trial

Anixa Biosciences Announces Positive Survival Data from Phase 1 Ovarian Cancer CAR-T Therapy Trial

Anixa Biosciences Announces Positive Survival Data from Phase 1 Ovarian Cancer CAR-T Therapy Trial
Trendline Trendline
Ukko Begins Clinical Trial for Innovative Peanut Allergy Treatment

Ukko Begins Clinical Trial for Innovative Peanut Allergy Treatment

Ukko Begins Clinical Trial for Innovative Peanut Allergy Treatment
Trendline Trendline
Arrowhead Pharmaceuticals Reports Strong Fiscal 2026 Second Quarter Results Amid Expanding RNAi Therapeutics

Arrowhead Pharmaceuticals Reports Strong Fiscal 2026 Second Quarter Results Amid Expanding RNAi Therapeutics

Arrowhead Pharmaceuticals Reports Strong Fiscal 2026 Second Quarter Results Amid Expanding RNAi Therapeutics
Trendline Trendline
ParcelBio Secures $13M to Advance Programmable mRNA Platform for Durable Medicines

ParcelBio Secures $13M to Advance Programmable mRNA Platform for Durable Medicines

ParcelBio Secures $13M to Advance Programmable mRNA Platform for Durable Medicines
Trendline Trendline
Altasciences and Certara Partner to Enhance Early Drug Development with Model-Informed Approaches

Altasciences and Certara Partner to Enhance Early Drug Development with Model-Informed Approaches

Altasciences and Certara Partner to Enhance Early Drug Development with Model-Informed Approaches
Trendline Trendline
Passengers Experience Intense Fog Inside Plane Cabin Due to Air Conditioning

Passengers Experience Intense Fog Inside Plane Cabin Due to Air Conditioning

Passengers Experience Intense Fog Inside Plane Cabin Due to Air Conditioning
Trendline Trendline
TRexBio Presents Data Supporting TNFR2 Agonism for Atopic Dermatitis Treatment

TRexBio Presents Data Supporting TNFR2 Agonism for Atopic Dermatitis Treatment

TRexBio Presents Data Supporting TNFR2 Agonism for Atopic Dermatitis Treatment
Trendline Trendline
NFL Announces 2026 Schedule Release with International Games

NFL Announces 2026 Schedule Release with International Games

NFL Announces 2026 Schedule Release with International Games